Capsinolol
Chemical compound
- none
- N-{4-[2-Hydroxy-3-(isopropylamino)propoxy]-3-methoxybenzyl}nonanamide
- 9887704
- 8063376
- ChEMBL366352
- DTXSID401031593
- Interactive image
- CCCCCCCCC(=O)NCC1=CC(=C(C=C1)OCC(CNC(C)C)O)OC
InChI
- InChI=1S/C23H40N2O4/c1-5-6-7-8-9-10-11-23(27)25-15-19-12-13-21(22(14-19)28-4)29-17-20(26)16-24-18(2)3/h12-14,18,20,24,26H,5-11,15-17H2,1-4H3,(H,25,27)
- Key:REOKPCLNKKXKDT-UHFFFAOYSA-N
Capsinolol is a beta blocker derived from nonivamide. It is the first beta blocker with an associated calcitonin gene-related peptide releasing activity in the heart.[1]
References
- ^ Chen IJ, Yeh JL, Lo YC, Sheu SH, Lin YT (Sep 1996). "Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart". Br J Pharmacol. 119 (1): 7–14. doi:10.1111/j.1476-5381.1996.tb15670.x. PMC 1915742. PMID 8872350.
- v
- t
- e
Adrenergic receptor modulators
- See also: Receptor/signaling modulators
- Dopaminergics
- Serotonergics
- Monoamine reuptake inhibitors
- Monoamine releasing agents
- Monoamine metabolism modulators
- Monoamine neurotoxins
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e